Patent · US Active

Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines

US9938275B2 · kind B2 · utility

0Cited by
197References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 23, 2017
Grant dateApr 10, 2018
Priority date
Expiry dateJan 23, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D471/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Imidazo-quinoline, -pyridine, and -naphthyridine ring systems (particularly quinolines, tetrahydroquinolines, pyridines, [1,5]naphthyridines, [1,5]tetrahydronaphthyridines) substituted at the 1-position with a cyclic substituent, pharmaceutical compositions containing the compounds, methods of making these compounds, and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.